日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Psychometric properties and detectability of GPT-4o-generated multiple-choice questions compared with human-authored items across imaging specialties

GPT-4o 生成的多项选择题与人工编写的题目在影像学各专业领域的心理测量学特性和可检测性比较

Linde, Philipp; Fichter, Florian; Dietlein, Markus; Sudbrock, Ferdinand; Afshar, Kambiz; Dapper, Hendrik; Fokas, Emmanouil; Hillebrecht, Anna-Lena; Raupach, Tobias; Laupichler, Matthias Carl

Bacteriophages as Food Biocontrol Agents: A One Health Framework for Manufacturing Quality, Regulatory Governance, and Ethical Stewardship-A Narrative Review

噬菌体作为食品生物防治剂:面向生产质量、监管治理和伦理管理的“同一健康”框架——叙述性综述

Fokas, Rafail; Kalatzis, Panos G; Vantarakis, Apostolos

ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer

ESTRO关于直肠癌GTV勾画和剂量递增的共识指南

Chiloiro, Giuditta; Romano, Angela; Beets-Tan, Regina; Bujko, Krzysztof; Cusumano, Davide; Fokas, Emmanouil; Haustermans, Karin; Huguet, Florence; Intven, Martijn Pw; Marijnen, Corrie Am; Nacci, Ilaria; Nagtegaal, Iris D; Peters, Femke P; Stewart, Alexandra; Valentini, Vincenzo; Gambacorta, Maria Antonietta

Comparative Investigation and Trends of Respiratory Viruses Using Wastewater-Based Epidemiological Surveillance in Patras, Greece

希腊帕特雷市基于废水流行病学监测的呼吸道病毒比较调查及趋势分析

Anastopoulou, Zoi; Fokas, Rafail; Koukouvini, Kalypso-Angeliki; Chatziantoniou, Angeliki; Vantarakis, Apostolos

Assessing the quality of radiation oncology education in four German medical schools: a student perspective and comparison with DEGRO recommendations

评估德国四所医学院放射肿瘤学教育质量:学生视角及与德国放射肿瘤学会(DEGRO)建议的比较

Linde, Philipp; Lang, Frauke; Matuschek, Christiane; Schlenter, Marsha; Scafa, Davide; Neuwahl, Judith; Mäurer, Matthias; Oertel, Michael; Dapper, Hendrik; Fokas, Emmanouil; Klein, Marie; Baues, Christian

Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

接受全直肠系膜切除术或选择性观察等待治疗后新辅助治疗患者的生存情况:CAO/ARO/AIO-12 和 OPRA 随机 II 期试验的汇总分析

Williams, H; Fokas, E; Diefenhardt, M; Lee, C; Verheij, F S; Omer, D M; Lin, S T; Dunne, R F; Marcet, J; Cataldo, P; Polite, B; Piso, P; Polat, B; Dapper, H; Ghadimi, M; Hofheinz, R D; Qin, L-X; Saltz, L B; Wu, A J; Gollub, M J; Smith, J J; Weiser, M R; Rödel, C; Garcia-Aguilar, J

Clinical Reasoning: A 66-Year-Old Female Patient With Rapidly Progressive Memory Changes

临床推理:一名66岁女性患者出现快速进展性记忆力改变

Fokas, Jennifer A; Guo, KuangHua; Mejia Bautista, Melissa; Kimchi, Eyal Y; Dixit, Karan; Brat, Daniel; Jia, Dan Tong

Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison

局部晚期直肠癌术前放化疗和手术后化疗:CAO/ARO/AIO-12试验5年结果——一般两两比较

Diefenhardt, M; Kosmala, R; Fleischmann, M; Martin, D; Hofheinz, R-D; Ghadimi, M; Rödel, C; Polat, B; Fokas, E

Corrigendum to "mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)": [ESMO Open 9 (2024) 103703]

对“mFOLFOX6 与 mFOLFOX6 + aflibercept 作为 MRI 定义的 T3 直肠癌新辅助治疗:德国直肠癌研究组 (CAO/ARO/AIO 0214) 和 ABCSG (R-06) 的随机 II 期试验”的更正:[ESMO Open 9 (2024) 103703]

Hofheinz, R-D; Herrle, F; Dechow, T; von Weikersthal, L F; Welslau, M; Lettmaier, S; Burkart, C; Kubicka, S; Kochen, L; Merx, K; Krause, K; Ebert, M; Rödel, C; Fokas, E; Ghadimi, M; Reissfelder, C; Gaiser, T

BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides

BRF110 是一种口服活性 Nurr1-RXRα 选择性雷西诺类药物,可在不升高甘油三酯的情况下增强 BDNF 表达。

Xenophon Asvos,Mohamed A El Mubarak,Theodoros Karampelas,Theodoros Rampias,Constantin Tamvakopoulos,Gregory B Sivolapenko,Athanasios Papakyriakou,Stavros Topouzis,Demetrios K Vassilatis,Demosthenes Fokas